Inventor · disambiguated record
Yoram Sela
Also filed as: SELA YORAM
13 granted patents·18 pending applications·25 citations·filing 2002–2022
87Inventor score
Top patents by PatentIndex Score
31 records- 0190US11026908B2Extended release dosage forms of pregabalinMAPI PHARMA LTD·Filed 2017·Granted Jun 8, 2021·3 cites·10 claims
- 0283US11426365B2Compositions comprising thymoquinone and omega-3 fatty acidsTRINUTRA LTD·Filed 2018·Granted Aug 30, 2022·2 cites·14 claims
- 0382US10493122B2Sublingual delivery of glatiramer acetateMAPI PHARMA LTD·Filed 2015·Granted Dec 3, 2019·5 cites·8 claims
- 0475US10159702B2Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamineTRINUTRA LTD·Filed 2017·Granted Dec 25, 2018·2 cites·19 claims
- 0568US2021260006A1Extended release dosage forms of pregabalinMAPI PHARMA LTD·Filed 2021·Application pending·0 cites
- 0667US8062666B2Extended release compositions comprising as active compound venlafaxine hydrochlorideSELA YORAM·Filed 2002·Granted Nov 22, 2011·2 cites·2 claims
- 0765US11266701B2Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamineTRINUTRA LTD·Filed 2018·Granted Mar 8, 2022·0 cites·17 claims
- 0865US2023102251A1Compositions comprising thymoquinone and omega-3 fatty acidsTRINUTRA LTD·Filed 2022·Application pending·0 cites
- 0962US2008063703A1Active Drug Delivery in the Gastrointestinal TractGROSS YOSSI·Filed 2007·Application pending·0 cites
- 1060US8969417B2Pharmaceutical compositions for treatment of Parkinsons diseaseLAMENSDORF ITSCHAK·Filed 2009·Granted Mar 3, 2015·0 cites·5 claims
- 1157US2008038333A1Formulations For Poorly Soluble DrugsBIO DAR LTD·Filed 2005·Application pending·0 cites
- 1255US2023134563A1Sublingual cannabinoid compositionsALVIT LCS PHARMA LTD·Filed 2022·Application pending·0 cites
- 1355US2005058701A1Active drug delivery in the gastrointestinal tractFiled 2004·Application pending·0 cites
- 1454US8557282B2Extended release compositions comprising as active compound venlafaxine hydrochlorideSELA YORAM·Filed 2011·Granted Oct 15, 2013·0 cites·3 claims
- 1554US7585283B2Device and method for examining a body lumenGIVEN IMAGING LTD·Filed 2004·Granted Sep 8, 2009·11 cites·27 claims
- 1654US2006177497A1Gellan gum based oral controlled release dosage forms-a novel platform technology for gastric retentionBIO DAR LTD·Filed 2004·Application pending·0 cites
- 1753US2009035369A1Composition and Methods for Treating and Preventing Age-Related Macular DegenerationSELA YORAM·Filed 2007·Application pending·0 cites
- 1852US2010291200A1Formulations for poorly soluble drugsLYCORED BIO LTD·Filed 2010·Application pending·0 cites
- 1949US2003190354A1Extended release composition comprising as active compound venlafaxine hydrochlorideFiled 2003·Application pending·0 cites
- 2049US2008085248A1Controlled Long Acting Release Pharmaceutical Preparation For Use In The Oral CavitySELA YORAM·Filed 2005·Application pending·0 cites
- 2145US2021379063A1Oral aminodihydrophthalazinedione compositions and their use in the treatment of non-viral hepatitisIMMUNOPHARMA PLUS D O O·Filed 2019·Application pending·0 cites
- 2245US2020170994A1Sublingual cannabinoid compositionsSELA YORAM·Filed 2018·Application pending·0 cites
- 2343US10675269B2Compositions comprising melatoninTRINUTRA LTD·Filed 2017·Granted Jun 9, 2020·0 cites·13 claims
- 2443US2009069417A1Carotenoid oxidation products as chemopreventive and chemotherapeutic agentsSHARONI YOAV·Filed 2006·Application pending·0 cites
- 2542US2004158194A1Oral devices and methods for controlled drug releaseWOLFF ANDY AND BEISKI BEN Z·Filed 2003·Application pending·0 cites
- 2641US2004267240A1Active drug delivery in the gastrointestinal tractFiled 2004·Application pending·0 cites
- 2740US9259418B2Pharmaceutical compositions for treatment of Parkinson's diseasePHARMATWOB LTD·Filed 2015·Granted Feb 16, 2016·0 cites·5 claims
- 2840US2004253304A1Active drug delivery in the gastrointestinal tractFiled 2004·Application pending·0 cites
- 2938US11103458B2Stimulant abuse-deterrent compositions4P PHARMA·Filed 2016·Granted Aug 31, 2021·0 cites·13 claims
- 3038US9943489B2Extended release formulations of rasagiline and uses thereofSELA YORAM·Filed 2011·Granted Apr 17, 2018·0 cites·25 claims
- 3138US2020222348A1Bimodal modified release compositions for cancer treatmentMUSLI THYROPEUTICS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yoram Sela files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →